期刊文献+

免疫性血小板减少症发病机制研究最新进展 被引量:24

Latest Advance of Study on Pathogenesis of Immune Thrombocytopenia——Review
下载PDF
导出
摘要 免疫性血小板减少症(immune thrombocytopenia,ITP)被公认为是多因子起源的、细胞特异性的自身免疫性疾病,目前对其发病机制仍不十分清楚。传统观念认为,自身抗体介导的血小板破坏是ITP的病理生理学机制,但近年来的许多研究表明,T淋巴细胞、树突状细胞(DC)、自然杀伤细胞(NK细胞)、细胞因子、细胞程序性死亡(PCD)、氧化应激(OS)、感染、妊娠和药物等因素的异常对其发病有着重要作用。近年来,对免疫性血小板减少症的研究取得了一系列重要成果,本文将对其发病机制研究最新进展做一综述。 Immune thrombocytopenia( ITP) is recognized as a multifactorial cell-specific autoimmune disorder,and its pathogenesis is still not very clear. Traditional concept suggests that the platelet destruction mediated by autoantibodies is the pathophysiology mechanism of ITP,w hile many studies in recent years have show n that the abnormities of T lymphocyte,dendritic cell( DC),natural killer cell( NK),cytokine,programmed cell death( PCD),oxidative stress( OS),infection,pregnancy and drugs etc play an important role in the pathogenesis of ITP. Since the study of ITP has made a series of important achievements in recent years,this review focuses on the latest advance of studies on pathogenesis of ITP.
作者 杨敏 刘文君
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2016年第3期958-962,共5页 Journal of Experimental Hematology
基金 四川省教育厅重点科研基金资助(2011ZA150)
关键词 免疫性血小板减少症 发病机制 免疫紊乱 immune thrombocytopenia pathogenesis immunodeficiency
  • 相关文献

参考文献2

  • 1Tetsuya Nishimoto,Masataka Kuwana.CD4 + CD25 + Foxp3 + Regulatory T Cells in the Pathophysiology of Immune Thrombocytopenia[J].Seminars in Hematology.2013
  • 2HIROKAZU KASHIWAGI,YOSHIAKI TOMIYAMA.Pathophysiology and management of primary immune thrombocytopenia. International Journal of Hematology . 2013

共引文献5

同被引文献242

引证文献24

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部